BRPI1006947B1 - composição, vacina para aves da ordem galliformes e usos das mesmas - Google Patents

composição, vacina para aves da ordem galliformes e usos das mesmas Download PDF

Info

Publication number
BRPI1006947B1
BRPI1006947B1 BRPI1006947A BRPI1006947A BRPI1006947B1 BR PI1006947 B1 BRPI1006947 B1 BR PI1006947B1 BR PI1006947 A BRPI1006947 A BR PI1006947A BR PI1006947 A BRPI1006947 A BR PI1006947A BR PI1006947 B1 BRPI1006947 B1 BR PI1006947B1
Authority
BR
Brazil
Prior art keywords
strain
mycoplasma gallisepticum
fact
composition
vaccine
Prior art date
Application number
BRPI1006947A
Other languages
English (en)
Portuguese (pt)
Inventor
Stanley H. Kleven
Naola M. Ferguson
Original Assignee
University Of Georgia Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Georgia Research Foundation, Inc. filed Critical University Of Georgia Research Foundation, Inc.
Publication of BRPI1006947A2 publication Critical patent/BRPI1006947A2/pt
Publication of BRPI1006947B1 publication Critical patent/BRPI1006947B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI1006947A 2009-01-22 2010-01-22 composição, vacina para aves da ordem galliformes e usos das mesmas BRPI1006947B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14647209P 2009-01-22 2009-01-22
PCT/US2010/021749 WO2010085611A2 (en) 2009-01-22 2010-01-22 Mycoplasma gallisepticum formulation

Publications (2)

Publication Number Publication Date
BRPI1006947A2 BRPI1006947A2 (pt) 2016-10-04
BRPI1006947B1 true BRPI1006947B1 (pt) 2020-02-04

Family

ID=42356391

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006947A BRPI1006947B1 (pt) 2009-01-22 2010-01-22 composição, vacina para aves da ordem galliformes e usos das mesmas

Country Status (9)

Country Link
US (1) US8668912B2 (https=)
EP (1) EP2389433B1 (https=)
JP (1) JP5642710B2 (https=)
KR (1) KR101715159B1 (https=)
CN (1) CN102292432B (https=)
BR (1) BRPI1006947B1 (https=)
CA (1) CA2749213C (https=)
MX (1) MX2011007732A (https=)
WO (1) WO2010085611A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2943219T4 (pl) * 2012-09-10 2022-08-22 Susan Szathmary Szczepionka do zapobiegania zakażeniu mykoplazmalnemu u ptactwa wodnego
CN106967829A (zh) * 2017-05-18 2017-07-21 隋兆峰 一种鉴别mg 6/85株的套式pcr检测方法
CN110218808B (zh) * 2019-06-28 2021-07-13 华中农业大学 滑液囊支原体和鸡毒支原体的四重pcr检测试剂盒
CN119816588A (zh) * 2022-04-06 2025-04-11 乔治亚大学研究基金公司 鸡毒支原体活疫苗
US20260014240A1 (en) * 2022-07-20 2026-01-15 University Of Connecticut Rationally designed mycoplasma gallisepticum subunit vaccine
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196514A (en) 1990-03-06 1993-03-23 The University Of Georgia Research Foundation, Inc. Method of detecting mycoplasma infection in poultry and compositions therefor
WO1993001276A1 (en) 1991-07-12 1993-01-21 Smithkline Beecham Corporation Continuous cell line and vaccine against avian coccidia
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
US7785822B2 (en) 2002-08-27 2010-08-31 University Of Georgia Research Foundation, Inc. Assays for the detection of biliverdin in birds and reptiles
US20070178115A1 (en) 2005-08-15 2007-08-02 Tang De-Chu C Immunization of avians by administration of non-replicating vectored vaccines

Also Published As

Publication number Publication date
HK1161289A1 (zh) 2012-08-24
BRPI1006947A2 (pt) 2016-10-04
CA2749213A1 (en) 2010-07-29
WO2010085611A2 (en) 2010-07-29
CA2749213C (en) 2017-08-15
KR20110123748A (ko) 2011-11-15
CN102292432B (zh) 2013-05-22
KR101715159B1 (ko) 2017-03-10
US8668912B2 (en) 2014-03-11
EP2389433A2 (en) 2011-11-30
WO2010085611A3 (en) 2010-11-25
CN102292432A (zh) 2011-12-21
MX2011007732A (es) 2011-11-04
EP2389433B1 (en) 2015-11-25
JP5642710B2 (ja) 2014-12-17
US20120021005A1 (en) 2012-01-26
JP2012515552A (ja) 2012-07-12
EP2389433A4 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
Blackall et al. Infectious coryza and related bacterial infections
US6231871B1 (en) Live in ovo vaccine
Marouf et al. Inactivated pentavalent vaccine against mycoplasmosis and salmonellosis for chickens
CN119816588A (zh) 鸡毒支原体活疫苗
Patnayak et al. Experimental and field evaluation of a live vaccine against avian pneumovirus
Ferreira et al. Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens
US8668912B2 (en) Mycoplasma gallisepticum formulation
KR20120016282A (ko) 마이코플라스마　하이오뉴모니에의 온도 감수성 백신 균주 및 그의 용도
Perelman et al. Use of controlled exposure as a novel method for reovirus arthritis/tenosynovitis prevention. A preliminary report
Ferguson-Noel et al. Evaluation of Mycoplasma gallisepticum K-strain as a live vaccine in chickens
US7217420B2 (en) Mycoplasma gallisepticum formulation
Mohammadi et al. Combination of H120 and 793/B types of infectious bronchitis virus vaccine protects chickens against challenge with OX like strain of the virus
HK1161289B (en) Mycoplasma gallisepticum formulation
US20250186512A1 (en) Live mycoplasma synoviae vaccine
KR101360112B1 (ko) 공기전파가 가능한 신규한 ｈ９ｎ２형 저병원성 조류인플루엔자 바이러스 균주 및 그로부터 유래된 백신
Liu et al. A newly developed temperature-sensitive Mycoplasma synoviae live attenuated strain prevents pathological lesions of the respiratory and reproductive tracts in chickens caused by a wild-type M. synoviae strain
Adamu et al. Evaluation of the protective efficacy of Salmonella Gallinarum 9R strain vaccine against Salmonella strains isolated from cases suspected of salmonellosis outbreaks in poultry farms in central Ethiopia
Raheem et al. Continental Veterinary Journal
US20140186385A1 (en) Potomac horse fever isolates
Ferguson The evaluation of a live Mycoplasma gallisepticum vaccine candidate and DNA sequence analysis in the molecular epidemiology of Mycoplasma gallisepticum

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2472 DE 22/05/2018 POR TER SIDO INDEVIDA.

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/02/2020, OBSERVADAS AS CONDICOES LEGAIS.